These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 37419070)
1. Biokinetics, radiopharmacokinetics and estimation of the absorbed dose in healthy organs due to Technetium-99m transported in the core and on the surface of reconstituted high-density lipoprotein nanoparticles. Pérez-Velasco DL; Morales-Avila E; Ocampo-García B; Torres-García E; Izquierdo G; Jiménez-Mancilla N; Oros-Pantoja R; Díaz-Sánchez LE; Aranda-Lara L; Isaac-Olivé K Nucl Med Biol; 2023; 122-123():108363. PubMed ID: 37419070 [TBL] [Abstract][Full Text] [Related]
2. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z; Santos-Cuevas CL; Ocampo-García BE; Ferro-Flores G; García-Becerra R; Estrada G; Gómez-Argumosa E; Izquierdo-Sánchez V Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877 [TBL] [Abstract][Full Text] [Related]
8. Primary radiation dosimetry of a novel PET radiopharmaceutical Cheki M; Gali H Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263 [TBL] [Abstract][Full Text] [Related]
9. Formulation and Preclinical Testing of Tc-99m-Labeled HYNIC-Glc-FAPT as a FAP-Targeting Tumor Radiotracer. Yang X; Li G; Ruan C; Hu K; Tang G Bioconjug Chem; 2023 Nov; 34(11):2133-2143. PubMed ID: 37874952 [TBL] [Abstract][Full Text] [Related]
11. Anti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties. Li YC; Tan TZ; Zheng JG; Zhang C World J Gastroenterol; 2008 Apr; 14(14):2235-40. PubMed ID: 18407601 [TBL] [Abstract][Full Text] [Related]
13. Program for Determining the Dosimetric Contribution of Tc-99m Biokinetics in Estimating the Dose to the Heart of a Male Adult. Morales-Nizama RA; Gallozzo-Cárdenas MM; Chinchay-Espino HA; Murga-Torres E; Alvarez-Escobedo AM; Nazario-Naveda R J Med Phys; 2024; 49(1):1-5. PubMed ID: 38828064 [TBL] [Abstract][Full Text] [Related]
14. A Pretargeted Imaging Strategy for Immune Checkpoint Ligand PD-L1 Expression in Tumor Based on Bioorthogonal Diels-Alder Click Chemistry. Qiu L; Tan H; Lin Q; Si Z; Mao W; Wang T; Fu Z; Cheng D; Shi H Mol Imaging Biol; 2020 Aug; 22(4):842-853. PubMed ID: 31741201 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of Functionalized Polysaccharide Microparticles Dosimetry for SPECT Imaging Based on Biodistribution Data of Rats. Desbrée A; Bonnard T; Blanchardon E; Petiet A; Franck D; Chauvierre C; Le Visage C Mol Imaging Biol; 2015 Aug; 17(4):504-11. PubMed ID: 25537093 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a New Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611 [TBL] [Abstract][Full Text] [Related]
17. Development of technetium-99m labeled ultrafine gold nanobioconjugates for targeted imaging of folate receptor positive cancers. Kumar D; Sakhare N; Das S; Kale P; Mathur A; Mirapurkar S; Muralidharan S; Chaudhari P; Mohanty B; Ballal A; Patro P Nucl Med Biol; 2021 Feb; 93():1-10. PubMed ID: 33212346 [TBL] [Abstract][Full Text] [Related]
19. Relationship of In Vitro Toxicity of Technetium-99m to Subcellular Localisation and Absorbed Dose. Costa IM; Siksek N; Volpe A; Man F; Osytek KM; Verger E; Schettino G; Fruhwirth GO; Terry SYA Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948266 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT. Li F; Cheng T; Dong Q; Wei R; Zhang Z; Luo D; Ma X; Wang S; Gao Q; Ma D; Zhu X; Xi L Nucl Med Biol; 2015 Mar; 42(3):256-62. PubMed ID: 25516099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]